z-logo
open-access-imgOpen Access
PHOENIX DACTYLIFERA LINN. (PIND KHARJURA): A REVIEW
Author(s) -
Ateeq Ahmad,
Soni Dutta Sunil,
Singh K Varun,
M. K. Santosh
Publication year - 2013
Publication title -
international journal of research in ayurveda and pharmacy
Language(s) - English
Resource type - Journals
eISSN - 2277-4343
pISSN - 2229-3566
DOI - 10.7897/2277-4343.04328
Subject(s) - phoenix dactylifera , phoenix , geography , palm , physics , archaeology , astronomy , metropolitan area
The medicinal plants are widely used by the traditional medical practitioners for curing various diseases in their day to day practice. Phoenix dactylifera Linn. (Pind Kharjura) is the most useful traditional medicinal plant in India. Its fruit is known as Date which is the edible part of the plant. It is now considered as a valuable source of unique natural products for development of medicines and used against various diseases. Its fruit contains high amount of tannins and are used in the different disease condition like raktapitta (heamorrhage), swasa (dyspnoea), kasa (cough), daha (burning sensation), murchha (syncope), abhighata (injury) and kshaya (tuberculosis). The fruits are rich source of carbohydrates, vitamins, and proteins. Its fruit is sweet (madhura), astringent (kasaya) in taste. Now-a-days its fruit is being used in the different Ayurvedic formulation for the treatment of various diseases. It has different pharmacological action like antibacterial, anti-inflammatory, anti-diabetic, anti-asthamatic, nephroprotective, hepatoprotective and aphrodisiac activities. Phytochemical investigation shows that the fruit contains anthocyanins, phenolics, sterols, carotenoids, and flavonoids. Present review highlights phytopharmacological and different traditional uses of Phoenix dactylifera Linn. which is mention in ancient Ayurvedic texts. This review stimulates the researchers and scientists for further work on Phoenix dactylifera

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here